Anbio Biotechnology Class A Ordinary Shares (NNNN) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $1.44B, listed on NASDAQ, employing roughly 27 people, carrying a beta of 4.66 to the broader market. Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. Led by Michael Lau, public since 2025-02-19.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for NNNN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →